| Zdroj: |
Drug Week; 4/14/2023, p1957-1957, 1p |
| Abstrakt: |
Keywords: Bronchodilators; Business; Drugs and Therapies; GlaxoSmithKline plc; Health and Medicine; Methylxanthines; Pharmaceutical Companies; Pharmaceuticals; Respiratory Agents; Theophylline Therapy EN Bronchodilators Business Drugs and Therapies GlaxoSmithKline plc Health and Medicine Methylxanthines Pharmaceutical Companies Pharmaceuticals Respiratory Agents Theophylline Therapy 1957 1957 1 04/10/23 20230414 NES 230414 2023 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on respiratory agents are presented in a new report. For more information on this research see: Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline. [Extracted from the article] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
